Bottom line
PBRIX vs NVDL: the short answer
PBRIX (Federated Hermes Prudent Bear Fund) and NVDL (GraniteShares 2x Long NVDA Daily ETF) are both mutual funds.
But PBRIX is far broader, holding 184 positions to 11 for NVDL, so beyond the top names it adds exposure NVDL doesn't have.
NVDL is cheaper at 1.64% vs 2.43% — a difference of $79 a year per $10,000 invested.
Over one year, NVDL returned +32.5% vs −11.9% for PBRIX (reporting dates differ).
Updated Nov 19, 2026
PBRIX vs NVDL side by side
| PBRIX | NVDL | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Federated Hermes | Graniteshares |
| Category | Leveraged & Inverse | Leveraged & Inverse |
| Expense ratio | 2.43% | 1.64% |
| Annual cost per $10k | $243 | $164 |
| 10-yr cost on $10k (prospectus) | $3,003 | $1,951 |
| Max front load | 0% | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | −11.9% | +32.5% |
| 5-yr return (annualized) | −12.9% | — |
| 10-yr return (annualized) | −12.4% | — |
| Best quarter | — | +178.6% |
| Worst quarter | — | −44.1% |
| Net assets (fund) | $90.0M | $4.1B |
| Number of holdings | 184 | 11 |
| Portfolio turnover | 249% | 1,059,7% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
PBRIX and NVDL share none of their top holdings.
PBRIX top 10
- Federated Hermes Money Market Obligations Trust — 58.59%
- United States Treasury — 27.59%
- Innoscripta Se — 0.73%
- Csg Nv — 0.36%
- Sophia Genetics SA — 0.35%
- Pics Nv — 0.28%
- MNTN Inc — 0.27%
- Lumexa Imaging Holdings Inc — 0.26%
- Exzeo Group Inc — 0.26%
- Abbvie Inc — 0.22%
NVDL top 10
- Treasury Bill — 320.25%
- Clear Street — 125.36%
- Natixis Securities — 34.59%
- Nomura Securities — 17.65%
- Wells Fargo Securities, LLC — 8.92%
- Cantor Fitzgerald — 5.41%
- Goldman Sachs — 4.92%
- Treasury Bill — 3.70%
- BMO Capital Markets — 3.46%
- BofA Securities, Inc — 0.00%
FAQ
What is the difference between PBRIX and NVDL?
Which is cheaper, PBRIX or NVDL?
Should I own both PBRIX and NVDL?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.